Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vincristine sulfate liposome vs vincristine sulfate in adult acute lymphoblastic leukemia
CTR20131092Phase 3Active
- Sponsor
- Nanjing Sike Pharmaceutical
- Start
- May 2014
- Modality
- Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 3 trial of vincristine sulfate liposome in acute lymphoblastic leukemia (ALL), sponsored by Nanjing Sike Pharmaceutical. Started May 2014; status: active.
02
Drugs
vincristine sulfate liposome
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on CTR20131092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20131092.